Zobrazeno 1 - 10
of 182
pro vyhledávání: '"Marcel O Bonn-Miller"'
Autor:
Marcel O Bonn-Miller, Sue Sisley, Paula Riggs, Berra Yazar-Klosinski, Julie B Wang, Mallory J E Loflin, Benjamin Shechet, Colin Hennigan, Rebecca Matthews, Amy Emerson, Rick Doblin
Publikováno v:
PLoS ONE, Vol 16, Iss 3, p e0246990 (2021)
ImportanceThere is a pressing need for development of novel pharmacology for the treatment of Posttraumatic Stress Disorder (PTSD). Given increasing use of medical cannabis among US military veterans to self-treat PTSD, there is strong public interes
Externí odkaz:
https://doaj.org/article/82e33b022335422aaffc481f330b29ae
Publikováno v:
Biomedicines, Vol 12, Iss 7, p 1551 (2024)
Cannabielsoin (CBE) is primarily recognized as an oxidation byproduct of cannabidiol (CBD) and a minor mammalian metabolite of CBD. The pharmacological interactions between CBE and cannabinoid receptors remain largely unexplored, particularly with re
Externí odkaz:
https://doaj.org/article/dbcb16ea056b4660912088d736fc1d13
Autor:
Mehdi Haghdoost, Yossef López de los Santos, Megan Brunstetter, Morgan L. Ferretti, Matthew Roberts, Marcel O. Bonn-Miller
Publikováno v:
Pharmaceuticals, Vol 17, Iss 5, p 637 (2024)
Even slight structural differences between phytocannabinoid isomers are usually enough to cause a change in their biological properties. In this study, we used in vitro CB1 agonism/antagonism assays to compare the receptor binding functionality of TH
Externí odkaz:
https://doaj.org/article/1967a2bebcee41a896daf348a33b80d6
Autor:
Erica N. Peters, Helena Yardley, Amy Harrison, Graham M.L. Eglit, Jose Antonio, Cynthia Turcotte, Marcel O. Bonn-Miller
Publikováno v:
Journal of the International Society of Sports Nutrition, Vol 20, Iss 1 (2023)
ABSTRACTBackground Cannabinoid-containing products are marketed to athletes as promoting recovery, in spite of a lack of data on their safety and effects. This randomized, double-blind, placebo-controlled, repeated-dose pilot study tested the safety,
Externí odkaz:
https://doaj.org/article/0955398cc3024183a7441ef4a64b844e
Autor:
Helen Heussler, Jonathan Cohen, Natalie Silove, Nancy Tich, Marcel O. Bonn-Miller, Wei Du, Carol O’Neill, Terri Sebree
Publikováno v:
Journal of Neurodevelopmental Disorders, Vol 11, Iss 1, Pp 1-9 (2019)
Abstract Background Fragile X syndrome (FXS) is characterized by a range of developmental, neuropsychiatric, and behavioral symptoms that cause significant impairment in those with the disorder. Cannabidiol (CBD) holds promise as a potential treatmen
Externí odkaz:
https://doaj.org/article/3b5a2d811d91482ebf1a0edc66cee477
Autor:
Joshua A. Lile, Brian W. Turner, David H. Cox, Marcel O. Bonn-Miller, Ned R. Katz, Thomas P. Shellenberg, William W. Stoops, Justin C. Strickland
Publikováno v:
Journal of Addiction Medicine. 17:e87-e93
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::3190114768eae27c17382e889fee6262
https://doi.org/10.1097/adm.0000000000001059
https://doi.org/10.1097/adm.0000000000001059
Autor:
Laura MacNair, Irina Mosesova, Jonathon C. Arnold, Maia G. Etchart, Lyndsey L. Anderson, M Hunter Land, Marcel O. Bonn-Miller
Publikováno v:
Cannabis Cannabinoid Res
INTRODUCTION: Legalization of medicinal cannabis around the world has led to an increase in the use of commercial cannabis-based products in the community. These cannabis-based products are being used in combination with conventional drugs to treat a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ecbf07f9f24deed5dd2ef2c3bbbf8d92
https://doi.org/10.1089/can.2020.0053
https://doi.org/10.1089/can.2020.0053
Autor:
Megan Brunstetter, Alex Simonian, Kimberly A. Babson, Mallory J E Loflin, Hal S. Wortzel, Ryan Vandrey, Marcel O. Bonn-Miller
Publikováno v:
Cannabis Cannabinoid Res
INTRODUCTION: Given the increasing availability and use of cannabis among individuals with post-traumatic stress disorder (PTSD) and the addition of PTSD as an eligible diagnosis in several U.S. medical cannabis programs, the efficacy of dispensary-o
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::590013317a1b1da2086fe9e00e30911b
https://doi.org/10.1089/can.2020.0056
https://doi.org/10.1089/can.2020.0056
Autor:
M Hunter Land, Siva A. Vanapalli, Marton L. Toth, Marcel O. Bonn-Miller, Laura MacNair, Timothy W Lefever, Erica N. Peters
Publikováno v:
Cannabis and Cannabinoid Research. 6:522-527
Introduction: Despite widespread use of cannabidiol (CBD), no lifelong toxicity study has been published to date. Caenorhabditis elegans is often used in preclinical lifelong toxicity studies, due ...
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::2e53d5933a60568d25107c0e1ca04f58
https://doi.org/10.1089/can.2020.0103
https://doi.org/10.1089/can.2020.0103
Autor:
Ryan J. Scalsky, Ryan Vandrey, Mallory J E Loflin, Heather Jackson, Erin L. Martin, Nicolas J. Schlienz, Justin C. Strickland, Marcel O. Bonn-Miller, Joel Munson
Publikováno v:
Cannabis and Cannabinoid Research
Introduction: Despite widespread legalization, the impact of medicinal cannabis use on patient-level health and quality of life (QOL) has not been carefully evaluated. The objective of this study was to characterize self-reported demographics, health
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::dbb179979e3c3464bb702fd76d1d655a
https://doi.org/10.1089/can.2019.0096
https://doi.org/10.1089/can.2019.0096